4//SEC Filing
Shanler Stuart 4
Accession 0001209191-19-015882
CIK 0001557746other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 6:09 PM ET
Size
5.6 KB
Accession
0001209191-19-015882
Insider Transaction Report
Form 4
Shanler Stuart
Chief Scientific Officer
Transactions
- Award
Restricted stock units
2019-03-01+82,200→ 82,200 total→ Common Stock (82,200 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
- [F2]The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2020, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.
Documents
Issuer
Aclaris Therapeutics, Inc.
CIK 0001557746
Entity typeother
Related Parties
1- filerCIK 0001654332
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 6:09 PM ET
- Size
- 5.6 KB